166 Quality of life and pruritus in moderate bio-naive psoriasis patients treated with apremilast: 6-week interim results of a real-world, multicenter, prospective  study in Greece

The early impact of apremilast on the quality of life (QoL) and pruritus severity of adult bio-naive patients with moderate psoriasis was examined using the Dermatology Life Quality Index (DLQI), the EuroQol 5-dimensions (EQ-5D) instrument, and a pruritus Visual Analogue Scale (VAS, 10cm). 6-week data from the first 100 eligible patients [mean age: 49.9 years; 71.0% males; 41.0% obese; median disease duration: 8.0 years] that completed 24 weeks of observation (or were previously withdrawn) are presented, using last-observation carried forward missing data imputation.

Source: Journal of Investigative Dermatology - August 31, 2019 Category: Dermatology Authors: T. Spiliopoulos, A. Drosos, A. Malouchou, C. Tziortzioti, A. Protopapa, K. Krasagakis, E. Lazaridou, E. Zafiriou, N. Antonakopoulos, A. Koleta Tags: Clinical Research and Epidemiology Source Type: research